Regular price
Regular price
ClubBev! price
Checking availability...
Product details
- Size 2ct
- SKU 139087
Description
Fast. Easy. Ready When You Are. Rapid Results in 10 minutes.
QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home. Available over-the-counter, everything you need is in the package and taking the test is simple.
Key Features
Fast and easy test uses a nasal swab to help detect the novel coronavirus, SARS-CoV-2, that causes COVID-19
Get results in 10 minutes, in the privacy of home
No prescription, complicated procedures or training required
Identified positive cases 83.5% of the time and negative cases 99.2% of the time in a clinical study
How to Use the QuickVue At-Home OTC COVID-19 Test
Get your results with a gentle, self-collected anterior nasal (nares) swab sample. After collecting your sample, swirl the swab in a tube of reagent solution, remove it, and insert the test strip. Wait ten minutes and take the strip out of the tube to see your results.
Frequently Asked Questions
What is the QuickVue At-Home OTC COVID-19 Test?
The QuickVue At-Home OTC COVID-19 Test is an antigen test. Antigen tests are designed to detect proteins from the virus that causes COVID-19, in anterior nasal swabs.
How accurate is the test?
Based on the interim results of a clinical study where the QuickVue At-Home OTC COVID-19 Test was compared to an FDA-authorized molecular SARS-CoV-2 test, the QuickVue At-Home OTC COVID-19 Test correctly identified 83.5% of positive specimens and 99.2% of negative specimens. The performance of this test is still being studied in patients without signs and symptoms of respiratory infection and for serial screening. Performance may differ in these populations.
What is the difference between an antigen test and PCR or molecular tests?
An antigen test, such as the QuickVue At-Home OTC COVID-19 Test, detects proteins from the virus. Molecular tests detect genetic material from the virus. Antigen tests are very specific for the virus, but not as sensitive as molecular tests. This means that a positive result is highly accurate, but a negative result does not rule out infection. If your test result is negative, you should discuss with your healthcare provider on whether an additional test is necessary and if you should continue isolating at home.
How long should I wait between the first and second test? The QuickVue At-Home OTC COVID-19 Test is intended to be used for serial testing or used twice by the same individual over two to three days with at least 24 hours and no more than 36 hours between tests.
Learn More At: QuickVueAtHome.com
Quidel is a California-based leading diagnostic /QuickVueAtHome manufacturer focused on improving the quality of healthcare throughout the globe. As a trusted innovator in the medical device industry for over 40 years, Quidel launched the QuickVue brand in 1986 with visually read rapid diagnostics focusing on women’s health and respiratory diseases. In 1999, QuickVue Influenza A+B was the first visually read rapid test cleared by the FDA for professional use. Now, the QuickVue At-Home COVID-19 Test utilizes the same technology used for decades by healthcare professionals and makes simple, easy-to-use COVID-19 tests accessible for the good of our families, our communities, and the world.
Some or all of the cost of your COVID rapid tests may be reimbursable by your health insurance, please reach out to them directly or visit the Center for Medicare & Medicaid Services's website (www.CMS.gov) for more information.
View full details
QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home. Available over-the-counter, everything you need is in the package and taking the test is simple.
Key Features
Fast and easy test uses a nasal swab to help detect the novel coronavirus, SARS-CoV-2, that causes COVID-19
Get results in 10 minutes, in the privacy of home
No prescription, complicated procedures or training required
Identified positive cases 83.5% of the time and negative cases 99.2% of the time in a clinical study
How to Use the QuickVue At-Home OTC COVID-19 Test
Get your results with a gentle, self-collected anterior nasal (nares) swab sample. After collecting your sample, swirl the swab in a tube of reagent solution, remove it, and insert the test strip. Wait ten minutes and take the strip out of the tube to see your results.
Frequently Asked Questions
What is the QuickVue At-Home OTC COVID-19 Test?
The QuickVue At-Home OTC COVID-19 Test is an antigen test. Antigen tests are designed to detect proteins from the virus that causes COVID-19, in anterior nasal swabs.
How accurate is the test?
Based on the interim results of a clinical study where the QuickVue At-Home OTC COVID-19 Test was compared to an FDA-authorized molecular SARS-CoV-2 test, the QuickVue At-Home OTC COVID-19 Test correctly identified 83.5% of positive specimens and 99.2% of negative specimens. The performance of this test is still being studied in patients without signs and symptoms of respiratory infection and for serial screening. Performance may differ in these populations.
What is the difference between an antigen test and PCR or molecular tests?
An antigen test, such as the QuickVue At-Home OTC COVID-19 Test, detects proteins from the virus. Molecular tests detect genetic material from the virus. Antigen tests are very specific for the virus, but not as sensitive as molecular tests. This means that a positive result is highly accurate, but a negative result does not rule out infection. If your test result is negative, you should discuss with your healthcare provider on whether an additional test is necessary and if you should continue isolating at home.
How long should I wait between the first and second test? The QuickVue At-Home OTC COVID-19 Test is intended to be used for serial testing or used twice by the same individual over two to three days with at least 24 hours and no more than 36 hours between tests.
Learn More At: QuickVueAtHome.com
Quidel is a California-based leading diagnostic /QuickVueAtHome manufacturer focused on improving the quality of healthcare throughout the globe. As a trusted innovator in the medical device industry for over 40 years, Quidel launched the QuickVue brand in 1986 with visually read rapid diagnostics focusing on women’s health and respiratory diseases. In 1999, QuickVue Influenza A+B was the first visually read rapid test cleared by the FDA for professional use. Now, the QuickVue At-Home COVID-19 Test utilizes the same technology used for decades by healthcare professionals and makes simple, easy-to-use COVID-19 tests accessible for the good of our families, our communities, and the world.
Some or all of the cost of your COVID rapid tests may be reimbursable by your health insurance, please reach out to them directly or visit the Center for Medicare & Medicaid Services's website (www.CMS.gov) for more information.